Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
about
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.Influence of host microvascular environment on tumour vascular endothelium.Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyMolecular imaging of gliomas with PET: opportunities and limitations."...those left behind." Biology and oncology of invasive glioma cells.Mesenchymal migration as a therapeutic target in glioblastoma.Small molecule alpha(v) integrin antagonists: novel anticancer agents.A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma.Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooptionThe alpha v integrin antagonists as novel anticancer agents: an update.Cilengitide-induced temporal variations in transvascular transfer parameters of tumor vasculature in a rat glioma model: identifying potential MRI biomarkers of acute effects.In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapyIn vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.Antiangiogenic therapy for cancer: an updateSmall molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imagingTissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expressionMMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting αvβ3-mediated SDF-1/CXCR4 signaling.A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probesAntiangiogenic agents for the treatment of glioblastoma.Combining molecular targeted agents with radiation therapy for malignant gliomasNew molecular targets in angiogenic vessels of glioblastoma tumours.Biology of angiogenesis and invasion in gliomaCurrent available therapies and future directions in the treatment of malignant gliomas.Specific targeting of human integrin α(v)β (3) with (111)In-labeled Abegrin™ in nude mouse models.The brain tumor microenvironment.The brain tumor microenvironment.Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions.Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells.Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis.Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential.Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
P2860
Q33375093-AC2FEB48-4960-4F50-BAE6-CE15D1491F22Q33655353-95D31073-9784-48EB-8BD2-4963BB60E99AQ33829590-DF0731E0-14E8-4323-ACF1-91C9D95ECF6FQ33961188-18BC250B-63CB-48FF-9C27-6A531B90A6E7Q33997839-B0CC6B2E-F426-4D03-A27B-5379ADA549ABQ34002994-7478BC3B-10B7-4A04-AA05-1082714FEEB5Q34074899-26B3CA9B-05B5-402C-9936-AEC880113033Q34141247-AF08578B-3086-464B-AD71-76E18CF8F59BQ34198775-9D3B682C-9D4E-41FC-A70B-D5B708BD826CQ34997337-5DCC1301-B45B-4C71-B6DC-4C24384AA893Q35011900-3F83AB25-02AB-4DA2-8E14-AAB55627B8BCQ35078406-FA04F5F0-81C0-43DE-881D-F1502EE1C537Q35085398-22913C02-3A18-4AB6-8C43-911EF62D17CCQ35148491-7CF3A9EA-8163-44BC-BF0E-BD1C780FEA4CQ35800448-DBAA0FBF-99C3-458B-B918-69279A0F8C7CQ35869077-08DCAE96-C9FB-42F8-8E31-BEC7744E2E87Q36103026-42736A27-D9FF-4615-AFA5-C707A9D3923DQ36244724-E03C1231-1D15-4B63-9151-5B47FDB116A1Q36563542-779E5017-C2C5-43B8-89D4-C68570AD8D2BQ36610302-0095832D-FC5A-4684-A256-A61AC969CCD3Q36620970-2E48701B-7D6C-4E57-9B5C-77B996339ED8Q36650689-0C464CCF-B6C9-40B0-8CD2-CA3E44729962Q36694514-99D9D556-68AA-4E74-AD2B-076124CF8952Q37016086-F9120061-CC50-48E7-A85A-447845654C9DQ37099594-76079448-5C9D-4B8B-96DE-98C9B52AB290Q37106536-BF199671-5C74-42FF-A05B-C24A27E2AC7CQ37533625-89888F27-1CBD-43E3-BD57-564211400E58Q37586907-000DDEA5-D52C-4957-A442-CDFB7966624AQ37592073-332B677B-DAEA-4C71-AE57-9E1955FD918FQ37858940-96AAD1F8-66B9-4767-8FBF-5C19E8308820Q37989468-5FF49E54-D8E1-4299-8D9A-A18B7F2C6108Q38155932-EE953C46-B6C5-4B76-8D0E-9797EFA73B77Q38242534-64D0ECC7-E7EF-4A02-BCC2-5B56F149382CQ38398188-B08A517F-7B43-47CD-9DE4-560EFF821857Q39060605-45011748-844D-4F00-9920-2AB4CCDD7ED0Q39467094-C8E2D6C5-1B11-488A-BD68-15A68E81A061Q39986415-346D60AF-5B44-42D6-9E8F-B07A6B85473EQ40222503-630D0F0C-3D4F-4B58-9A71-3C8547E12475Q40980125-35906067-7135-4FC5-A5A5-A0D3340B5BBBQ41093681-984F4ADB-74E5-47B9-94AB-F06E1AD89AFE
P2860
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@en
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@nl
type
label
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@en
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@nl
prefLabel
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@en
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@nl
P1476
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
@en
P2093
Gladson CL
P304
P356
10.1097/00005072-199611000-00005
P577
1996-11-01T00:00:00Z